NEJM Evidence study: colorectal cancer rising in nearly every age group up to 69
- On 27 October 2026 NEJM Evidence published a University of Chicago study on US colorectal cancer rates.
- The overall colorectal cancer rate rose from 36.7 to 38.3 per 100,000 between 2022 and 2023, the first rise in over 20 years.
- Adults aged 45–49 saw the steepest increase, 12.76% a year from 2019 to 2023.
- Rates are also rising at ages 65–69, even though about 80% of this group is up to date with screening.
On 27 October 2026 NEJM Evidence published a study led by Caitlin Murphy of the University of Chicago showing that rising colorectal cancer rates are no longer limited to young adults but now extend to nearly all age groups up to 69 in the United States.
What the study found
The team analysed 20 years of National Cancer Institute data. The age-adjusted incidence rate fell from 55.2 per 100,000 in 2000 to 36.7 in 2022, then rose to 38.3 in 2023, the first increase in the overall rate in more than 20 years.
Also read: EMA recommends daraxonrasib for metastatic pancreatic cancer after a fast-tracked phased review
- Adults aged 45–49 had the sharpest rise, 12.76% a year from 2019 to 2023, which the authors say is likely driven partly by lowering the screening start age from 50 to 45.
- Rates are rising at ages 65–69 and have plateaued at 70–74, even though about 80% of these groups are up to date with screening.
- The increase persisted even when 2020–2021 data affected by COVID-19 were excluded.
A birth cohort effect
Murphy describes a birth cohort effect: people born in the 1960s and later carry higher risk, and as they age, rates rise in older groups too. This suggests unknown risk factors may be offsetting the gains from screening.
Limits
The study uses US cancer registry data only and does not identify the causes of the rise. A one-year jump also needs follow-up in coming years to confirm the trend.
Sources: UChicago Medicine, CP24
This story is relayed from the source named above; responsibility for its content rests with the original source.
FAQ
What did the NEJM Evidence study find about colorectal cancer?
The NEJM Evidence study published in October 2026 found that US colorectal cancer rates are rising in nearly all age groups up to 69, and that the overall rate rose for the first time in more than 20 years.
Which age group has the fastest rise in colorectal cancer?
Adults aged 45–49 had the fastest rise in colorectal cancer, 12.76% a year from 2019 to 2023, partly linked to screening now starting at 45.
Is colorectal cancer also rising in older adults?
Yes. According to the study, colorectal cancer rates are rising at ages 65–69 and have stopped falling at 70–74, despite about 80% of these groups being up to date with screening.
What is the birth cohort effect in colorectal cancer?
The birth cohort effect means people born in the 1960s and later face higher colorectal cancer risk, so as they age, rates rise in older age groups too.
Does COVID-19 explain the rise in colorectal cancer?
No. The rise in colorectal cancer persisted even after excluding 2020–2021 data, and screening had largely returned to pre-pandemic levels by January 2021, according to the University of Chicago researchers.



